Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01
Topiramate Tablet
Product Images NDC 71335-0047
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02
This is a chart showing cumulative rates for time to the first seizure comparing two groups: Topiramate 50 mg/day (N=234) and Topiramate 400 mg/day (N=236) over a period of 500 days.*
Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03
This text provides information about a change in the average monthly migraine period rate during the double-blind phase of a study involving the use of Topamax at 100 mg/day and 200 mg/day. The results indicate an increase in the migraine rate, with statistical significance indicated by the symbols (*p < 0.010, **p < 0.001).*
Label Image (Lbl713350047)
This is a description of a medication called Topiramate, available as pink capsules of 125mg by Cipla. The medication can also be found in tablet form, with each tablet containing 200mg of Topiramate. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F), and the container should be kept tightly closed. This particular packaging contains 30 tablets and the expiration date is mentioned as MM/YY. The NDC (National Drug Code) is 71335-0047-1, and the product is identified by the UPC code 04947301523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
